Arecor Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	25	30	28	56	73	111
Market Cap Growth	55.29%	9.52%	-50.35%	-23.94%	-34.00%	-
Enterprise Value	19	29	25	48	60	89
Last Close Price	0.66	0.81	0.73	1.82	2.40	4.00
PE Ratio	23.51	45.77	-	-	-	-
PS Ratio	14.54	17.73	5.49	12.22	30.58	96.15
PB Ratio	3.86	4.71	5.19	5.87	4.21	6.00
P/TBV Ratio	3.87	4.72	5.22	8.97	5.23	6.01
EV/Sales Ratio	11.02	16.73	5.04	10.46	24.94	77.27
EV/EBITDA Ratio	16.47	25.01	-	-	-	-
EV/EBIT Ratio	20.27	30.77	-	-	-	-
Debt / Equity Ratio	0.02	0.02	0.04	0.04	0.02	0.01
Debt / EBITDA Ratio	0.09	0.09	-	-	-	-
Net Debt / Equity Ratio	-0.93	-0.93	-0.57	-0.67	-0.72	-0.97
Net Debt / EBITDA Ratio	-5.26	-5.26	0.43	0.72	1.23	3.07
Net Debt / FCF Ratio	2.45	2.45	0.33	1.07	1.13	3.28
Asset Turnover	0.20	0.20	0.42	0.25	0.11	0.09
Inventory Turnover	-	-	5.62	3.49	-	-
Quick Ratio	4.35	4.35	2.08	1.96	4.19	8.77
Current Ratio	4.78	4.78	2.53	2.17	4.69	9.05
Return on Equity (ROE)	15.79%	15.79%	-137.62%	-63.41%	-51.44%	-63.85%
Return on Assets (ROA)	6.93%	6.93%	-38.43%	-30.88%	-30.28%	-29.64%
Return on Invested Capital (ROIC)	207.08%	63.65%	-272.54%	-227.95%	-382.93%	-3568.36%
Return on Capital Employed (ROCE)	14.40%	14.40%	-135.50%	-89.70%	-57.30%	-32.00%
Earnings Yield	2.66%	2.19%	-36.88%	-15.30%	-12.60%	-5.54%
FCF Yield	-9.88%	-8.10%	-33.07%	-10.72%	-15.08%	-4.96%
Buyback Yield / Dilution	0.72%	0.72%	-9.20%	-5.83%	-25.63%	-41.77%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.